Logistic regression; independent factors associated withIGVH gene status
| Factors . | % with unmutated V gene status (n) . | Unadjusted odds ratio (95% CI) . | Odds ratio (95% CI) after adjusting for other 3 independent predictors . | P after adjusting for other 3 independent predictors . |
|---|---|---|---|---|
| CD38 | ||||
| < 30% | 17% (17) | — | — | |
| ≥ 30% | 62% (44) | 8.0 (3.9, 16.2) | 5.4 (2.3, 12.4) | < .001 |
| Chromosome 11 abnormality | ||||
| N | 37% (63) | — | — | |
| Y | 64% (16) | 3.1 (1.3, 7.4) | 5.2 (1.5, 18.3) | .010 |
| Morphology | ||||
| Typical | 25% (33) | — | — | |
| Atypical | 69% (47) | 6.6 (3.5, 12.7) | 4.6 (1.9, 11.0) | .001 |
| Chromosome 13 abnormality | ||||
| N | 50% (58) | — | — | |
| Y | 27% (24) | 0.4 (0.2, 0.7) | 0.4 (0.2, 0.8) | .02 |
| Factors . | % with unmutated V gene status (n) . | Unadjusted odds ratio (95% CI) . | Odds ratio (95% CI) after adjusting for other 3 independent predictors . | P after adjusting for other 3 independent predictors . |
|---|---|---|---|---|
| CD38 | ||||
| < 30% | 17% (17) | — | — | |
| ≥ 30% | 62% (44) | 8.0 (3.9, 16.2) | 5.4 (2.3, 12.4) | < .001 |
| Chromosome 11 abnormality | ||||
| N | 37% (63) | — | — | |
| Y | 64% (16) | 3.1 (1.3, 7.4) | 5.2 (1.5, 18.3) | .010 |
| Morphology | ||||
| Typical | 25% (33) | — | — | |
| Atypical | 69% (47) | 6.6 (3.5, 12.7) | 4.6 (1.9, 11.0) | .001 |
| Chromosome 13 abnormality | ||||
| N | 50% (58) | — | — | |
| Y | 27% (24) | 0.4 (0.2, 0.7) | 0.4 (0.2, 0.8) | .02 |